Synergistic regulatory effects of TNF α, IL-1 α or and IFN α on the growth and differentiation of Daudi lymphoma cells

Cell Biology International

Volumn 20, Issue 5, 1996, Pages 335-338

  Santavenere, E ^a   Di Pietro, R ^a   Centurione, M A ^b   Di Domenicantonio, L ^b   Trubiani, O ^a   Rana, R A ^a  

^a Ist di Morfologia Umana Normale   (Italy)

^b CNR   (Italy)

Author keywords

Cytokines; Daudi cells; Differentiation; Growth

Indexed keywords

FC RECEPTOR; INTERLEUKIN 1ALPHA; MONOCLONAL ANTIBODY; RECOMBINANT ALPHA2A INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DAUDI CELL; HUMAN; HUMAN CELL; LYMPHOMA CELL;

EID: 0030150649     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1006/cbir.1996.0037     Document Type: Article

References (18)

1. BENJAMIN D, WORMSLEY S, DOWERE SK, 1990. Eterogeneity in interleukin (IL)-1 receptors expressed on human B cell lines. J Biol Chem 265: 9943-9951.
2. BIANCO C, PATRICK R, NUSSENZWEIG W, 1970. A population of lymphocytes bearing a membrane receptor for antigen-antibody complement complexes. J Exp Med 132: 702-720.
3. CHANG JR, HE LEE S, 1986. Effects of interferon-γ and tumor necrosis factor-α on the expression of an Ia antigen on a murine macrophage cell line. J Immunol 137: 2853-2856.
4. DENT CL, LILLYCROP KA, BYBEE A, LATCHMAN DS, THOMAS NS, 1991. Interferon-alpha treatment of Daudi cells down-regulates the octamer binding transcription/DNA replication factors oct-1 and oct-2. J Biol Chem 266: 20888-20892.
5. FRIEDMANN RM, 1986. Growth factors, oncogenes and interferons. J Exp Pathol 2: 223-228.
6. LOVETT D, KOZAN B, HADAM M, RESCH K, GIEMSA D, 1986. Macrophage cytotoxicity: interleukin 1 as a mediator of tumor cytostasis. J Immunol 136: 340-347.
7. MISCIA S, CATALDI A, GRIMLEY PM, 1989. Influence of phosphatidylcholine on two protein mRNA levels in Interferon treated Daudi cells. Cell Biol Int Rep 13: 595-599.
8. NAKAMURA S, NAKATA K, KASHIMOTO S, YOSHIDA H, YAMADA M, 1986. Antitumor effect of recombinant human interleukin 1 alpha against murine syngenic tumors. Jpn J Cancer Res 77: 767-773.
9. ONOZAKI K, MATSUCHIMA K, AGGARWAL B, OPPENHEIM JJ, 1985. Human interleukin 1 is a cytocydal factor for several tumor cell lines. J Immunol 135: 3962-3968.
10. ONOZAKI K, TAMATANI T, HASHIMOTO T, MATSUCHIMA K, 1987. Growth inhibition and augmentation of mouse myeloid leukemic cell line differentiation by interleukin 1. Cancer Res 47: 2397-2402.
11. ONOZAKI K, URAWA H, TAMATANI T, et al., 1988. Synergistic interaction of interleukin 1, interferon-beta and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon beta is an autocrine differentiating factor. J Immunol 140: 112-119.
12. PFEFFER LM, STRULOVICI B, SALTIEL AR, 1990. Interferon-α selectively activates the β isoform of protein kinase C through phosphatidylcholine hydrolysis. Proc Natl Acad Sci USA 87:6537-6541.
13. ROSS GD, 1981. Detection of complement receptors and Fc receptors on macrophages. In HERSCOWITZ HB, et al. eds. Manual of Macrophage Methodology Vol. 13. Marcel Dekker. New York, 209-227.
14. RUGGIERO V, TAVERNIER J, FIERS W, BAGLIONI C, 1986. Induction of the synthesis of tumor necrosis factor receptors by interferon-γ. J Immunol 136: 2445-2450.
15. SANTAVENERE E, CATALDI A, RANA R, et al., 1991. Nuclear metabolic changes induced by tumor necrosis factor in Daudi lymphoma cells; a multi-parametric analysis. Cell Biol Int Rep 15: 1235-1242.
16. SANTAVENERE E, DI PIETRO R, CENTURIONE MA, TRUBIANI O, ZAMAI L, RANA R, 1994. IL-1 alpha antiproliferative and differentative effects on Daudi lymphoma cells: multiparametric analysis. Cell Biol Int 18: 777-782.
17. SHUAI K, 1994. Interferon-activated signal transduction to the nucleus. Curr Biol 6: 253-259.
18. TSUJIMOTO M, FEINMAN R, VILCEK J, 1986. Differential effects of type 1 IFN and IFN-γ on the binding of tumor necrosis factor to receptors in two human cell lines. J Immunol 137: 2272-2277.